Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: Comparison with clinical and radiologic examinations

Head and Neck

Volumn 25, Issue 4, 2003, Pages 280-288

  Liu, Ming ^a   Lawson, Georges ^a   Delos, Monique ^a   Jamart, Jacques ^a   Ide, Christophe ^a   Coche, Emmanuel ^b   Weynand, Birgit ^b   Desuter, Gauthier ^b   Hamoir, Marc ^b   Remacle, Marc ^a   Marbaix, Etienne ^b  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Carcinoma; Head and neck; Ki67; Metastasis; PCNA

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER CELL; CANCER STAGING; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL FRACTIONATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROLIFERATING CELL NUCLEAR ANTIGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 0037379531     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10218     Document Type: Article

References (33)

1. Ferlito A, Rinaldo A. False negative conventional histology of lymph nodes in patients with head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2000;62:112-114.
2. Snyderman NL, Johnson JT, Schramm VL Jr, et al. Extracapsular spread of carcinoma in cervical lymph nodes: impact upon survival in patients with carcinoma of the supraglottic larynx. Cancer 1985;56:1597-1599.
3. Galioto G, Mevio E, Benazzo M, Arizzi L, Scelsi M. Prognostic parameters in metastatic spread of laryngeal cancer: clinicopathological correlations. Clin Otolaryngol 1987;13:303-308.
4. Don DM, Anzai Y, Lufkin RB, Fu YS, Calcaterra TC. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995;105:669-674.
5. Remacle M, Hamoir M, Marbaix E, Deggouj N, Frederickx Y. Interest in frozen section examination of margins and lymph nodes in laryngeal surgery. J Laryngol Otol 1988;102:818-821.
6. van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11-17.
7. Merritt RM, Williams MF, James TH, Porubsky ES. Detection of cervical metastasis. A meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg 1997;123:149-152.
8. Mancuso AA, Harnsberger HR, Muraki AS, Stevens MH. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part II. Pathology. Radiology 1983;148:715-723.
9. Feinmesser R, Freeman JL, Noyek AM, Birt D, Gullane P, Mullen JB. MRI and neck metastases: a clinical, radiological, pathological correlative study. J Otolaryngol 1990;19:136-140.
10. Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 1997;7:774-783.
11. Kau RJ, Alexiou C, Stimmer H, Arnold W. Diagnostic procedures for detection of lymph node metastases in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000;62:199-203.
12. Mathews MB, Berstein RM, Franza BR, Garrels JI. Identification of the proliferating cell nuclear antigen and cyclin. Nature 1984;303:374-376.
13. Schluter C, Duchrow M, Wohlenberg C, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-522.
14. Liu M, Lawson G, Delos M, Jamart J, Remacle M. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma. Acta Otorhinolaryngol Belg 1997;51:129-135.
15. Franchi A, Gallo O, Boddi V, Santucci M. Prediction of occult neck metastasis in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 1996;2:1801-1808.
16. Dobros W, Rys J, Niezabitowski A, Olszewski E. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx. Auris Nasus Larynx 1998;25:295-301.
17. Krecicki T, Jelen M. Proliferating cell nuclear antigen in laryngeal cancer. J Laryngol Otol 1998;112:310-313.
18. Golusinski W, Olofsson J, Szmeja Z, Biczysko W, KrygierStojalowska A, Kulczynski B. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer. Eur Arch Otorhinolaryngol 1999;256:306-311.
19. Sarac S, Ayhan A, Hosal AS, Kaya S. Prognostic significance of PCNA expression in laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998;124:1321-1324.
20. Broich G, Lavezzi AM, Biondo B, Pignataro LD. PCNA-a cell proliferation marker in vocal cord cancer. Part II. Recurrence in malignant laryngeal lesions. In Vivo 1996;10:175-178.
21. Takes RP, Baatenburg de Jong RJ, Schuuring E, et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:412-419.
22. International Union Against Cancer (UICC). Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997. p 17-37.
23. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
24. Ambrosch P, Kron M, Fischer G, Brinck U. Micrometastases in carcinoma of the upper aerodigestive tract: detection, risk of metastasizing, and prognostic value of depth of invasion. Head Neck 1995;17:473-479.
25. Spiro RH, Gallo O, Shah JP. Selective jugular node dissection in patients with squamous carcinoma of the larynx or pharynx. Am J Surg 1993;166:399-402.
26. Leon X, Quer M, Orus C, Sancho FJ, Bague S, Burgues J. Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: A therapeutic option for the NO neck. Head Neck 2001;23:441-446.
27. Buckley JG, MacLennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000;22:380-385.
28. Gallo O, Fini-Storchi I, Napolitano L. Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-3). Head Neck 2000;22:386-392.
29. Rassekh CH, Johnson JT, Myers EN. Accuracy of intraoperative staging of the NO neck in squamous cell carcinoma. Laryngoscope 1995;105:1334-1336.
30. John DG, Anaes FC, Williams SR, et al. Palpation compared with ultrasound in the assessment of malignant cervical lymph nodes. J Laryngol Otol 1993;107:821-823.
31. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastasis. Radiology 1998;207:123-130.
32. Ferlito A, Devaney KO, Rinaldo A, Devaney SL, Carbone A. Micrometastases: have they an impact on prognosis? Ann Otol Rhinol Laryngol 1999;108:1185-1189.
33. Bocca E. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective. Ann Otol Rhinol Laryngol 1991;100:261-267.